Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
Distribution Industry Remained Efficient and Resilient During First Year of COVID-19
Data released by the Healthcare Distribution Alliance (HDA) Research Foundation indicate that despite the challenges of COVID-19, pharmaceutical distributors maintained efficiencies to deliver millions of vaccines and medicines to providers — and ultimately patients. Published today, the 92nd Edition HDA Factbook: The Facts, Figures & Trends in Healthcare provides benchmarks and trends for the U.S. pharmaceutical supply chain.
Advocacy in Action: Mutual Drug Meets With Rep. Foushee, Pharmacy Community About Industry Priorities
During the past few months, HDA member Mutual Drug has been actively involved in advocacy and supply chain partner discussions to underscore the value of pharmaceutical distributors and to provide perspective on policy issues affecting the supply chain.
Learn more about the company's tour with Representative Valerie Foushee (D-N.C.-04) at its headquarters in Durham, N.C. and their mid-July summit held in Durham focused on state and federal legislative issues impacting independent pharmacies.
HDA Honors Pharmaceutical and Consumer Product Manufacturer Members with DIANA Awards
The Healthcare Distribution Alliance (HDA) honored nine pharmaceutical and consumer product manufacturers with Distribution Industry Awards for Notable Achievements in Healthcare (DIANA Awards) at the 2023 HDA Business and Leadership Conference in Colorado Springs, Colo.
Davis Spotlights HDA's 2021 Strategic Priorities
HDA will be carrying forward the early lessons learned from COVID-19 pandemic and supporting response efforts in 2021, writes President and CEO Chip Davis in the January 4 issue of Chain Drug Review — particularly as distributors play a role in the largest public vaccination effort in recent memory. Davis provided his perspective on the year ahead, along with other healthcare trade association leaders, as part of the publication’s 2021 “Pharmacy Outlook” feature.
Partnering in Response to COVID-19
The evolving COVID-19 “coronavirus” pandemic has upended the lives and routines of almost every American across the country. It is during these challenging times, however, that communities have shown their resolve by coming together to tackle problems and support one another.